参考文献/References:
[1] 世界中医药学会联合会骨质疏松专业委员会,上海中医药大学附属龙华医院,中日友好医院,等.骨质疏松性骨折中西医结合诊疗专家共识[J].世界中医药,2023,18(7):895-900.
[2] 中华医学会骨科学分会.骨质疏松性骨折诊疗指南(2022年版)[J].中华骨科杂志,2022,42(22):1473-1491.
[3] 中华中医药学会.骨质疏松性骨折中医诊疗指南[J].中医正骨,2023,35(1):1-9.
[4] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022年版)[J].中国全科医学,2023,26(14):1671-1691.
[5] KNOPP-SIHOTA J A,NEWBURN-COOK C V,HOMIK J,et al.Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures:a systematic review and meta-analysis[J].Osteoporos Int,2012,23(1):17-38.
[6] LOUIE G H,TEKTONIDOU M G,CABAN-MARTINEZ A J,et al.Sleep disturbances in adults with arthritis:prevalence,mediators,and subgroups at greatest risk.Data from the 2007 National Health Interview Survey[J].Arthritis Care Res(Hoboken),2011,63(2):247-260.
[7] 中华医学会骨科学分会青年骨质疏松学组,中国医师协会急救复苏专业委员会创伤骨科与多发伤学组,上海市中西医结合学会骨质疏松专业委员会.中国骨质疏松性骨折围手术期处理专家共识(2018)[J].中国临床医学,2018,25(5):860-866.
[8] 裴育,董进,李梅.维生素D与骨质疏松症[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(1):44-50.
[9] 王林,李春霖.钙剂和维生素D在老年骨质疏松症中的应用[J].中国临床保健杂志,2022,25(1):30-33.
[10] WIMALAWANSA S J.Vitamin D deficiency:effects on oxidative stress,epigenetics,gene regulation,and aging[J].Biology(Basel),2019,8(2):30.
[11] EBELING P R.Vitamin D and bone health:epidemiologic studies[J].Bonekey Rep,2014,3:511.
[12] LIAO R X,YU M,JIANG Y,et al.Management of osteoporosis with calcitriol in elderly Chinese patients:a systematic review[J].Clin Interv Aging,2014,9:515-526.
[13] STOCKTON K A,MENGERSEN K,PARATZ J D,et al.Effect of vitamin D supplementation on muscle strength:a systematic review and meta-analysis[J].Osteoporos Int,2011,22(3):859-871.
[14] 林华,夏维波.双膦酸盐治疗骨质疏松症的依从性管理和药物假期选择[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(2):103-109.
[15] 邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,8(5):371-374.
[16] 张禄锴,马剑雄,李风波,等.双膦酸盐类药物治疗骨质疏松症的研究进展[J].中华老年骨科与康复电子杂志,2017,3(3):184-187.
[17] 余伯龙,李义凯.使用双膦酸盐类药物的不良反应[J].中国骨质疏松杂志,2011,17(1):80-85.
[18] 万金红.唑来膦酸联合鲑降钙素治疗老年性骨质疏松的临床效果[J].临床合理用药,2023,16(22):57-59.
[19] 刘云,罗晓婷,李崇,等.雌激素治疗绝经后骨质疏松症的研究进展[J].实用临床医学,2020,21(10):91-96.
[20] 吴隆琦.雌激素替代治疗绝经后骨质疏松症引发的争议[J].中国临床康复,2003,7(3):452.
[21] HIOKI T,MATSUSHIMA-NISHIWAKI R,TOKUDA H,et al.Selective estrogen receptor modulators,acting as agonists of estrogen receptor α in osteoblasts,reduce the TGF-β-induced synthesis of macrophage colony-stimulating factor via inhibition of JNK signaling pathway[J].Biomed Res,2022,43(6):211-221.
[22] 方岩,朱涛.绝经后骨质疏松症的治疗进展[J].中国骨质疏松杂志,2019,25(8):1192-1200.
[23] JOHNSTON C B,DAGAR M.Osteoporosis in older adults[J].Med Clin North Am,2020,104(5):873-884.
[24] 马宁,张浩沙强,王志刚,等.地舒单抗在骨质疏松中的应用研究进展[J].临床医学进展,2023,13(8):13454-13463.
[25] 罗健,李东文.唑来膦酸对比地舒单抗治疗原发性骨质疏松研究进展[J].医学研究与战创伤救治,2023,36(3):317-323.
[26] 杜桂平,李玉坤,李敏,等.地舒单抗和特立帕肽治疗中国女性绝经后骨质疏松症的成本-效用分析[J].中国药房,2023,34(2):173-178.
[27] 张婧璇,王红梅,孔令希,等.地舒单抗注射液对比唑来膦酸注射液治疗绝经后骨质疏松症的系统评价及成本-效果分析[J].中国医院用药评价与分析,2023,23(4):480-484.
[28] 谷营营,董伟.特立帕肽治疗骨质疏松症的研究进展[J].医药导报,2022,41(9):1331-1334.
[29] 阿卜杜吾普尔·海比尔,阿里木江·玉素甫,买合木提·亚库甫,等.特立帕肽和双膦酸盐治疗绝经后骨质疏松性骨折有效及安全性的Meta分析[J].中国组织工程研究,2024,28(4):639-645.
[30] SILVERMAN S,MILLER P,SEBBA A,et al.The direct assessment of nonvertebral fractures in community experience(DANCE)study:2-year nonvertebral fragility fracture results[J].Osteoporos Int,2013,24(8):2309-2317.
[31] 黄国伟,毛伟,陈环,等.骨质疏松性椎体压缩骨折术后使用特立帕肽疗效的meta分析[J].中国医药科学,2023,13(1):183-186.
[32] 杨宝峰,陈建国.药理学[J].9版.北京:人民卫生出版社,2018:355.
[33] 中华医学会骨质疏松和骨矿盐疾病分会.男性骨质疏松症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(5):381-395.
[34] 张敏,郭雄.氟、锶与骨质疏松症[J].国外医学(医学地理分册),2005,26(2):53-55.
[35] 谢静,陈佳,陈曦,等.罗莫珠单抗与安慰剂治疗骨质疏松症疗效与安全性的meta分析[J].重庆医学,2022,51(24):4258-4262.
[36] SAAG K G,PETERSEN J,BRANDI M L,et al.Romosozumab or alendronate for fracture prevention in women with osteoporosis[J].N Engl J Med,2017,377(15):1417-1427.
[37] PAIK J,SCOTT L J.Romosozumab:a review in postmenopausal osteoporosis[J].Drugs Aging,2020,37(11):845-855.
相似文献/References:
[1]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩
骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[2]宋永枝,陈双玲.唑来膦酸静脉滴注联合鲑降钙素肌肉注射治疗
骨质疏松性长骨骨折[J].中医正骨,2016,28(01):70.
[3]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(强骨饮颗粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(04):16.
[4]陈建德,樊晓琦,夏炳江,等.球囊扩张部位对椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效及安全性的影响[J].中医正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):11.
[5]史晓林,王健,王博,等.脆性骨折的防治进展[J].中医正骨,2017,29(05):20.
[6]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨质疏松性桡骨远端骨折锁定钢板内固定术后腕关节功能恢复的影响因素分析[J].中医正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):39.
[8]王威,冯兴兵,王章富,等.口服药物联合手法松解及功能锻炼治疗神经根型颈椎病的疗效观察及作用机制研究[J].中医正骨,2017,29(09):70.
[9]齐英娜,王威,吴鑫杰,等.脊髓损伤后微循环的变化及微循环障碍的药物治疗进展[J].中医正骨,2017,29(10):47.
[10]丁志清,颜峰,喻灿明,等.椎体后凸成形术后非典型骨水泥植入综合征死亡1例[J].中医正骨,2017,29(11):76.